x

Global Atrial Fibrillation Devices Market developed rapidly, with an average growth rate of 8.64%

Author: QYResearch  |   Published Date: 2018-05-31   |   Views: 111



About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.


This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2018 to 2025.


The geographical segmentation includes North America, Europe, Asia-Pacific, South America and Middle East & Africa. North America holds the largest share in this market. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.


The major players in global Atrial Fibrillation Devices market include

St. Jude Medical

Boston Scientific

Biosense Webster

Medtronic

Japan Lifeline

AtriCure

Biotronik

Philips

Synaptic Medical

Osypka AG

MicroPort Scientific

CardioFocus

Lepu Medical

APT Med

TZ Medical

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
More Clients...